Rational use and stewardship of antibiotics in pediatric respiratory disease

Adilia Warris (Exeter, United Kingdom)

Source: ERS Courses: Paediatric respiratory infections
Number: 11
Disease area: Paediatric lung diseases, Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Adilia Warris (Exeter, United Kingdom). Rational use and stewardship of antibiotics in pediatric respiratory disease. ERS Courses: Paediatric respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotic stewardship in respiratory infections
Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats
Year: 2016


Antibiotic prescribing in acute respiratory infections – are we following guidelines?
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Auditing patterns of azithromycin use in respiratory disease
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Cost-effective antibiotic management of community acquired pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198
Year: 2004

Point of care respiratory viral testing (POCT): A novel service to target appropriate antimicrobial prescription and improve antibiotic stewardship.
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018




Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Are antimicrobials still the future of respiratory infection therapy?
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 33-39
Year: 2007



Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


The efficacy of antiviral therapy of acute respiratory infections in paediatric practice
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017


Improving adherence in paediatric respiratory disease
Source: Breathe 2013; 9: 268-277
Year: 2013

Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia
Source: Eur Respir J, 50 (3) 1602306; 10.1183/13993003.02306-2016
Year: 2017



Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017

Home management of chronic respiratory disease through the use of telemedicine
Source: Annual Congress 2009 - MP18 - Home management of chronic respiratory disease through the use of telemedicine
Year: 2009


Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012


Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 40-44
Year: 2007



Can CAP guideline adherence improve patient outcome in internal medicine departments?
Source: Eur Respir J 2008; 32: 902-910
Year: 2008



Barriers to new drug development in respiratory disease
Source: Eur Respir J 2015; 45: 1197-1207
Year: 2015